公司新闻 - 亚科因（Abbkine）—服务于细胞和蛋白研究全球用户

首页
技术中心
产品文献

或

货号	产品名称	文献标题	IF	杂志名称
ABL1030	β-Tubulin小鼠单克隆抗体（3G6）	TrkA promotes MDM2-mediated AGPS ubiquitination and degradation to trigger prostate cancer progression	2	Journal of Experimental & Clinical Cancer Research
ABL1030	β-Tubulin小鼠单克隆抗体（3G6）	Entada phaseoloides extract suppresses hepatic gluconeogenesis via activation of the AMPK signaling pathway	3	Virus Research 227 (2017): 240-244
ABL1030	β-Tubulin小鼠单克隆抗体（3G6）	NPAS3 regulates transcription and expression of VGF: implications for neurogenesis and psychiatric disorders	4	American Journal of Physiology-Lung Cellular and Molecular Physiology 310
ABL1030	β-Tubulin小鼠单克隆抗体（3G6）	A Small Molecule Inhibitor of Erg251 Makes Fluconazole Fungicidal by Inhibiting the Synthesis of the 14α-Methylsterols	6	Mbio
ABL1030	β-Tubulin小鼠单克隆抗体（3G6）	Depletion of Kupffer cells attenuates systemic insulin resistance, inflammation and improves liver autophagy in high-fat diet fed mice	2	Endocrine journal
ABL1030	β-Tubulin小鼠单克隆抗体（3G6）	TrkA promotes MDM2-mediated AGPS ubiquitination and degradation to trigger prostate cancer progression	13	Journal of Experimental & Clinical Cancer Research
ABL1030	β-Tubulin小鼠单克隆抗体（3G6）	Downregulation of VPS13C promotes cisplatin resistance in cervical cancer by upregulating GSTP1	6	Iscience
ABL1030	β-Tubulin小鼠单克隆抗体（3G6）	HPV E7-drived ALKBH5 promotes cervical cancer progression by modulating m6A modification of PAK5	9	Pharmacological Research
ABL1030	β-Tubulin小鼠单克隆抗体（3G6）	The Therapeutic Effect of Dexmedetomidine on Rat Diabetic Neuropathy Pain and the Mechanism	2	Biological & Pharmaceutical Bulletin
ABL1030	β-Tubulin小鼠单克隆抗体（3G6）	The regulation of glycogen synthase kinase-3β on the mesenchymal stem cell therapy in the lypopolysaccharide induced acute lung injury in rat	0	Int J Clin Exp Med

首页上一页 19 20 21 22 23 24 下一页尾页

赋能细胞研究与治疗 Enabling cell research and therapy

联系我们

全国服务热线： 400-6800-830

订购邮箱： service@abbkine.com

联系地址：武汉光谷生物医药加速器17号楼1号房2-3层

友情链接：

Copyright ©Abbkine Scientific Co., Ltd- 鄂ICP备10204150号-5

意见反馈

 在线咨询

扫码关注

微信公众号

返回顶部